Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach-Reference-Cited by-同舟云学术

Some essential clarifications: IQWiG comments on two critiques of the efficiency frontier approach

Published:2010-09-09 Issue:10 Volume:19 Page:1139-1141
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Econ.

Author:

Dintsios Charalabos-Markos,Gerber Andreas

Publisher

Wiley

Subject

Health Policy

Reference12 articles.

1. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease;Briggs;Medical Decision Making,2002

2. Bundesministerium für Gesundheit http://www.bmg.bund.de/cln_117/nn_1168258/SharedDocs/Standardartikel/DE/AZ/K/Glossar-Kosten-Nutzen-Bewertung/Stellungnahme.html 2010

3. The efficiency frontier approach to economic evaluation of health-care interventions;Caro;Health Economics,2010

4. Use of surrogate measures in cost-effectiveness analyses of lipid-lowering therapies;Delea;Value in Health,1998

5. Drummond M Rutten F http://www.ohe.org/page/publications/publication.cfm?catid=35&itemid=624 2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10 Jahre AMNOG: ‚Value-based Pricing‘ mit einem Monopsonisten und seine Implikationen für die gesetzlich intendierte Zielsetzung;Sozialer Fortschritt;2024-05-01

2. A systematic review of moral reasons on orphan drug reimbursement;Orphanet Journal of Rare Diseases;2021-06-30

3. The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?;Expert Review of Pharmacoeconomics & Outcomes Research;2018-07-18

4. Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC – Lessons from Two Continents;Frontiers in Pharmacology;2017-10-10

5. The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options;Value in Health;2017-02